3d
Hosted on MSNCHOP doctors named 'Disruptors of the Year' for groundbreaking sickle cell gene therapyThe Philadelphia Citizen is recognizing CHOP doctors Alexis Thompson and Dr. Stephan Grupp with the 'Disruptors of the Year' ...
Nearly a year after new sickle cell gene therapies were approved, CNBC's Bertha Coombs reports a small number of patients are ...
In December 2023, through the development efforts of CRISPR Therapeutics and Vertex Pharmaceuticals, their decades-long ...
A new review and policy statement underscore the inaccuracy of sickle cell trait as a cause of death on autopsies.
On a family vacation, 14-year-old Jaden Hartley discovered he needed a heart transplant after experiencing this symptom. Now ...
Right now, approximately 20 billion red blood cells are busy traveling through your blood vessels. They are delivering oxygen ...
Bluebird Bio will sell itself to private equity firms Carlyle and SK Capital for about $30 million, the company said Friday.
There is a catch. If the private equity firms can boost sales of bluebird’s three gene therapies to $600 million—over any ...
As treatment and care continues to evolve, we must ensure that people living with this disease are able to advocate for ...
The Urban League of Greater Madison and The American Red Cross will host a Sickle Cell Awareness Blood Drive on Saturday, Feb ...
8d
The Daily Monitor on MSNGovt orders premarital sickle cell testing to curb disease burden“We still have a serious challenge with sickle cell disease, which contributes to 20% of under-five mortality every year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results